Roles of inflammation factors in melanogenesis
Top Cited Papers
Open Access
- 1 March 2020
- journal article
- review article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 21 (3), 1421-1430
- https://doi.org/10.3892/mmr.2020.10950
Abstract
The occurrence of hyperpigmentation or hypopigmentation after inflammation is a common condition in dermatology and cosmetology. Since the exact mechanism of its occurrence is not yet known, prevention and treatment are troublesome. Previous studies have confirmed that alpha-melanocyte-stimulating hormone, stem cell factor and other factors can promote melanogenesis-related gene expression through the activation of signaling pathways. Recent studies have revealed that a variety of inflammatory mediators can also participate in the regulation of melanogenesis in melanocytes. In this review, we summarized that interleukin-18, interleukin-33, granulocyte-macrophage colony stimulating factor, interferon-gamma, prostaglandin E2 have the effect of promoting melanogenesis, while interleukin-1, interleukin-4, interleukin-6, interleukin-17 and tumor necrosis factor can inhibit melanogenesis. Further studies have found that these inflammatory factors may activate or inhibit melanogenesis-related signaling pathways (such as protein kinase A and mitogen activated protein kinase) by binding to corresponding receptors, thereby promoting or inhibiting the expression of melanogenesis-related genes and regulating skin pigmentation processes. This suggests that the development of drugs or treatment methods from the perspective of regulating inflammation can provide new ideas and new targets for the treatment of pigmented dermatosis. This review outlines the current understanding of the inflammation factors' roles in melanogenesis.Keywords
This publication has 111 references indexed in Scilit:
- Methotrexate for the treatment of generalized vitiligoSaudi Pharmaceutical Journal, 2013
- A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the SkinJournal of Investigative Dermatology, 2012
- Cutaneous hypothalamic-pituitary-adrenal axis homolog: regulation by ultraviolet radiationAmerican Journal of Physiology-Endocrinology and Metabolism, 2011
- The Immune-Modulating Cytokine and Endogenous Alarmin Interleukin-33 Is Upregulated in Skin Exposed to Inflammatory UVB RadiationThe American Journal of Pathology, 2011
- Signaling pathways in melanosome biogenesis and pathologyThe International Journal of Biochemistry & Cell Biology, 2010
- IL-33 augments substance P–induced VEGF secretion from human mast cells and is increased in psoriatic skinProceedings of the National Academy of Sciences of the United States of America, 2010
- The cytokine interleukin-33 mediates anaphylactic shockProceedings of the National Academy of Sciences of the United States of America, 2009
- IL-33–activated dendritic cells induce an atypical TH2-type responseJournal of Allergy and Clinical Immunology, 2009
- Regulation of melanogenesis – controversies and new conceptsExperimental Dermatology, 2008
- IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cellsProceedings of the National Academy of Sciences of the United States of America, 2007